CEL-SCI Reports Third Consecutive Month of Record Patient Enrollment in '15 for Phase III Head, Neck Cancer Trial
April 01, 2015 at 08:48 AM EDT
CEL-SCI Corporation (NYSE: CVM) today announced that in March it has enrolled 29 patients with advanced primary, not yet treated, head ...
